America's GMO firms face China hurdle
Chinese consumer wariness over GMO safety has risen of late, and at the same time, Chinese regulatory approvals have ground to a near halt
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Kansas City, Missouri
WITH US approval for Dow AgroSciences' package of chemicals and new genetically engineered crops now in hand, the Dow Chemical Co unit faces a major obstacle to a US$1 billion market opportunity: Chinese import barriers.
The Asian nation has become a major buyer of US corn and soyabeans in recent years, but has also shown mounting reluctance to accept some genetically modified crops grown by US farmers. China for the last year has been rejecting US corn shipments containing traces of a type of GMO corn developed by Syngenta AG.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Amazon’s MGM Studios gains creative control over ‘James Bond’ franchise
UOB’s Wee Ee Cheong says S$4.9 billion Citi deal ‘paying off’ as Asean push accelerates
In taxing wealth, how far can Singapore push property owners?
